S66 Star Combo Pharma Limited
Consumer Defensive · Household & Personal Products
· website
$0.14
52wk 0.11 – 0.28
Overall
59.7
Value
100.0
Growth
71.9
Health
100.0
Quality
4.3
Momentum
18.5
Dividend
19.0
Price
About Star Combo Pharma Limited
Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company engages in the development, manufacturing, marketing, and sale of natural health supplements and skin care products and provision of Chinese health products through its e-commerce platform. It sells its products under the Living Healthy, Costar, Amax, and J&K brands. Star Combo Pharma Limited was founded in 2004 and is based in Smithfield, Australia.
Price analytics
Returns
| 1 day | 7.7% |
| 1 week | 0.0% |
| 1 month | 0.0% |
| 3 months | 7.7% |
| 6 months | -30.0% |
| 1 year | -40.4% |
| 3 years | 27.3% |
Risk
| Volatility (1y ann.) | 74.8% |
| Beta vs ASX 200 | 0.29 |
| Sharpe (1y) | -0.36 |
| VaR 95% (1-day) | -7.7% |
| Max drawdown (1y) | -59.3% |
| Off 1-year high | -48.1% |
Technicals
| RSI(14) | 50 |
| vs 50DMA | 3.9% |
| vs 200DMA | -21.5% |
| Trend | Death cross |
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value
100.0
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
100
Price / Book
100
Price / Sales
100
Growth
71.9
Revenue growth (1y)
44
Revenue CAGR (3y)
—
EPS growth (1y)
100
EPS CAGR (3y)
—
Financial Health
100.0
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow)
4.3
Return on equity
5
Return on assets
0
Operating margin
0
Net margin
11
Cash conversion (OCF / net income)
—
Dividend / Income
19.0
Dividend yield (%)
38
Payout ratio
0
FCF dividend cover
—
Momentum
18.5
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
70
Position in 52-week range
18
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).
Score history
Key metrics
Market cap
$18.91M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
0.00
Dividend yield
2.1%
Payout ratio
127.6%
Beta
0.35
EV / EBITDA
4.18
Price / Book
0.49
ROE
1.0%
Operating margin
-1.3%
Net margin
1.7%
Total cash
$18.01M
Total debt
$4.19M
Current ratio
3.86
Debt / Equity
0.11
Free cash flow
$16,319
Avg volume
21,958
Latest annual results
(FY ending 30 Jun 2025)
- Revenue—
- Gross profit—
- Operating income—
- Net income—
- Diluted EPS0.04
- Free cash flow—
- Net debt—